Social network
Our responsibility
 

Our approach

Olivier Brandicourt, Chief Executive Officer, Sanofi
May 2017

 

In 2016, we made strong progress on our 2020 strategic roadmap, as we transform into an agile and innovative global pharmaceutical leader serving the needs of patients worldwide. Our work in dynamic franchises – such as rare diseases, multiple sclerosis, and vaccines – and our performance in Emerging Markets enabled us to achieve solid financial results.

We believe that sustainability is business and that business is sustainability. We consider Corporate Social Responsibility (CSR) to be both a catalyst and a contributor to new and evolving business models. In our first integrated report, we emphasize our approach to integrated thinking within our organization and discuss how, by breaking down silos, Sanofi creates value over time for its diverse stakeholders.

One of our key priorities is Access to Healthcare for underserved populations. To that end, we are a founding partner of the Access Accelerated Initiative, an international coalition launched to address the burden of non-communicable diseases in lower income countries, with a goal of reducing premature deaths from those diseases by one third by 2030.

Our commitment to CSR is also illustrated by our longstanding adhesion to the United Nations Global Compact as well as our contribution to the achievement of the United Nations Sustainable Development Goals.

Discover the video Access Accelerated with Olivier Brandicourt:

Read more in the 2016 Integrated Report